Julien Taieb

Best Publications

• ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

  E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  3363
  Citations

• Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

  Christophe Louvet;R. Labianca;P. Hammel;G. Lledo

  1216
  Citations

• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

  Francois Ghiringhelli;Cédric Ménard;Magali Terme;Caroline Flament

  1208
  Citations

• VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

  Thibault Voron;Orianne Colussi;Elie Marcheteau;Simon Pernot

  1129
  Citations

• Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

  Valérie Vilgrain;Valérie Vilgrain;Helena Pereira;Eric Assenat;Boris Guiu

  917
  Citations

• Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

  Axel Grothey;Alberto F. Sobrero;Anthony F. Shields;Takayuki Yoshino

  898
  Citations

• FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

  Mustafa Suker;Berend R Beumer;Eran Sadot;Lysiane Marthey

  882
  Citations

• VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

  Magali Terme;Simon Pernot;Elie Marcheteau;Federico Sandoval

  700
  Citations

• A novel dendritic cell subset involved in tumor immunosurveillance.

  Julien Taieb;Nathalie Chaput;Cédric Ménard;Lionel Apetoh

  524
  Citations

• Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.

  Yung Jue Bang;E. Yañez Ruiz;E. Van Cutsem;K. W. Lee

  513
  Citations

• Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

  Sophie Viaud;Sophie Viaud;Magali Terme;Magali Terme;Caroline Flament;Caroline Flament;Julien Taieb;Julien Taieb

  496
  Citations

• Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

  Eric Tartour;H. Pere;B. Maillere;M. Terme

  407
  Citations

• SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

  Guy A. van Hazel;Volker Heinemann;Navesh K. Sharma;Michael P.N. Findlay

  387
  Citations

• First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

  Harpreet S Wasan;Peter Gibbs;Navesh K Sharma;Julien Taieb

  383
  Citations

• Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

  nathalie chaput;Samy Louafi;armelle Bardier;frederic charlotte

  347
  Citations

• Control of the immune response by pro-angiogenic factors.

  Thibault Voron;Elie Marcheteau;Simon Pernot;Orianne Colussi

  329
  Citations

• Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

  Julien Taieb;Josep Tabernero;Enrico Mini;Fabien Subtil

  300
  Citations

• Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.

  Charles S Fuchs;Kohei Shitara;Maria Di Bartolomeo;Sara Lonardi

  278
  Citations

• Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.

  Maximilien Barret;Sami Antoun;Cécile Dalban;David Malka

  274
  Citations

• Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

  Julien Taieb;Karine Le Malicot;Qian Shi;Frédérique Penault-Llorca

  264
  Citations